195 related articles for article (PubMed ID: 17917316)
1. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
Tanaka T; Tsutamoto T; Sakai H; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2007 Aug; 30(8):691-7. PubMed ID: 17917316
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
[TBL] [Abstract][Full Text] [Related]
3. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
[TBL] [Abstract][Full Text] [Related]
4. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402
[TBL] [Abstract][Full Text] [Related]
6. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
7. Effects of efonidipine, an L- and T-type calcium channel blocker, on the renin-angiotensin-aldosterone system in chronic hemodialysis patients.
Nakano N; Ishimitsu T; Takahashi T; Inada H; Okamura A; Ohba S; Matsuoka H
Int Heart J; 2010 May; 51(3):188-92. PubMed ID: 20558909
[TBL] [Abstract][Full Text] [Related]
8. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress.
Morimoto S; Jo F; Maki K; Iwasaka T
Clin Exp Hypertens; 2009 Feb; 31(1):83-91. PubMed ID: 19172462
[TBL] [Abstract][Full Text] [Related]
9. Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.
Uno H; Ishikawa J; Hoshide S; Kabutoya T; Ishikawa S; Shimada K; Kario K
Hypertens Res; 2008 May; 31(5):887-96. PubMed ID: 18712044
[TBL] [Abstract][Full Text] [Related]
10. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K
J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
Yamagishi T
Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
[TBL] [Abstract][Full Text] [Related]
13. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
15. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Konoshita T; Kaeriyama S; Urabe M; Nakaya T; Yamada M; Ichikawa M; Yamamoto K; Sato S; Imagawa M; Fujii M; Makino Y; Zenimaru Y; Wakahara S; Suzuki J; Ishizuka T; Nakamura H;
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515419
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
17. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
[TBL] [Abstract][Full Text] [Related]
18. Benidipine reduces albuminuria and plasma aldosterone in mild-to-moderate stage chronic kidney disease with albuminuria.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Hypertens Res; 2011 Feb; 34(2):268-73. PubMed ID: 21124330
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
[TBL] [Abstract][Full Text] [Related]
20. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]